Augmented TLR9-induced Btk activation in PIR-B–deficient B-1 cells provokes excessive autoantibody production and autoimmunity
暂无分享,去创建一个
S. Akira | M. Ono | A. Nakamura | T. Takai | T. Kubo | Y. Uchida | Yuko Watanabe | Masahiro Abe
[1] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[2] Hong Zhang,et al. The Inhibitory Receptor PIR-B Negatively Regulates Neutrophil and Macrophage Integrin Signaling1 , 2004, The Journal of Immunology.
[3] R. Hardy,et al. Rheumatoid factor secretion from human Leu-1+ B cells. , 1987, Science.
[4] A. Nakamura,et al. Exacerbated graft-versus-host disease in Pirb−/− mice , 2004, Nature Immunology.
[5] Kenneth G. C. Smith,et al. Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and FcγRII-mediated B Cell Suppression , 2002, The Journal of experimental medicine.
[6] E. Montecino-Rodriguez,et al. New perspectives in B-1 B cell development and function. , 2006, Trends in immunology.
[7] T. Takai,et al. Molecular Cloning of a Novel Murine Cell-surface Glycoprotein Homologous to Killer Cell Inhibitory Receptors* , 1997, The Journal of Biological Chemistry.
[8] D. Isenberg,et al. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. , 1990, Arthritis and rheumatism.
[9] A. Nakamura,et al. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation , 2007, The Journal of experimental medicine.
[10] F. Spertini,et al. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. , 1987, Journal of immunology.
[11] R. Eisenberg,et al. Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. , 1980, Clinical immunology and immunopathology.
[12] C. Feighery,et al. Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase* , 2007, Journal of Biological Chemistry.
[13] R. Berland,et al. Origins and functions of B-1 cells with notes on the role of CD5. , 2002, Annual review of immunology.
[14] Felicia A Tucci,et al. Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses. , 2006, Rheumatology.
[15] R. Zinkernagel,et al. Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.
[16] C. Mackay,et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells , 2007, The Journal of experimental medicine.
[17] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[18] Xuetao Cao,et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1 , 2008, Nature Immunology.
[19] Wolfgang Weninger,et al. Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-31 , 2007, The Journal of Immunology.
[20] R. Hardy. B-1 B cells: development, selection, natural autoantibody and leukemia. , 2006, Current opinion in immunology.
[21] Biochemical Nature and Cellular Distribution of the Paired Immunoglobulin-like Receptors, PIR-A and PIR-B , 1999, The Journal of experimental medicine.
[22] D. Walls,et al. Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus , 2007, Journal of Virology.
[23] T. Honjo,et al. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. , 1995, International immunology.
[24] M. Cooper,et al. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] V. Holers,et al. Innate autoimmunity. , 2005, Advances in immunology.
[26] M. Welham,et al. Molecular interactions of SHP1 and SHP2 in IL-3-signalling. , 2002, Cellular signalling.
[27] L. Genestier,et al. TLR Agonists Selectively Promote Terminal Plasma Cell Differentiation of B Cell Subsets Specialized in Thymus-Independent Responses1 , 2007, The Journal of Immunology.
[28] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[29] M. Kopf,et al. Toll-like receptors: paving the path to T cell-driven autoimmunity? , 2007, Current opinion in immunology.
[30] B. Beutler,et al. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity , 2007, Nature Medicine.
[31] B. Pulendran,et al. Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets , 2007, PloS one.
[32] A. Nakamura,et al. Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice , 2002, Nature Immunology.
[33] G. Lemke,et al. TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response , 2007, Cell.
[34] C. Chen,et al. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Newkirk. Rheumatoid factors: host resistance or autoimmunity? , 2002, Clinical immunology.
[36] R. Lovering,et al. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. , 1994, Human molecular genetics.
[37] E. Wong,et al. Bruton's Tyrosine Kinase Separately Regulates NFκB p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells* , 2008, Journal of Biological Chemistry.
[38] M. Clare-Salzler,et al. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .
[39] A. Nakamura,et al. FcγRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease , 2003, European journal of immunology.
[40] Hong Zhang,et al. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. , 2005, Immunity.
[41] A. Krieg,et al. Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity , 2007, Immunological reviews.
[42] J. Kinet,et al. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1 , 1999, Oncogene.
[43] L. Herzenberg,et al. Unraveling B-1 progenitors. , 2007, Current opinion in immunology.
[44] T. Kunikata,et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. , 1996, Blood.
[45] H. Zola,et al. Evaluation of CD5-positive B cells in blood and synovial fluid of patients with rheumatic diseases , 2004, Rheumatology International.
[46] L. Herzenberg,et al. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.